Anne Celle
Clinical Project Manager at SparingVision | Paris, Île-de-France, France
Anne Celle’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Clinical Project Manager at SparingVision in February 2021 - Present
Clinical Project Manager at DBV Technologies in October 2019 - December 2020
Deputy Clinical Project Manager at altizem in August 2018 - September 2019
Faculté d'Ingénierie et Management de la Santé, MASTER STS Ingenierie et Management de la Santé, January 2013 to January 2015
University of the West of Scotland, Honours Year, January 2013 to January 2014
Faculté d'Ingénierie et Management de la Santé, Licence STS mention Ingenierie et Santé Publique, January 2011 to January 2013
SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments. Founded to advance over 20 years of world-leading ophthalmic research from its scientific founders at the Paris Vision Institute, SparingVision is leading a step shift in how ocular diseases are treated, moving beyond single gene correction therapies. At the heart of this is a pipeline of gene independent treatments for rod-cone dystrophies. Lead products, SPVN06 and SPVN20, address mid and late stages of retinitis pigmentosa (RP)respectively. RP is the most common inherited retinal disease affecting two million people worldwide. These novel medicines could form the basis of a suite of new sight-saving treatments with potential applications across many other retinal diseases, regardless of genetic cause. The Company is supported by a strong, internationally renowned team who aim to harness the potential of genomic medicine to deliver new treatments to all ocular disease patients as quickly as possible. SparingVision has raised €60 million to date and its investors include 4BIO Capital, Advent France Biotechnology, Bpifrance, Foundation Fighting Blindness (US), Fondation Voir & Entendre, UPMC Enterprises, Jeito Capital and Ysios Capital. For more information, please visit www.sparingvision.com.
Discover more about SparingVisionHead of Clinical Operations for Gene Therapies chez SparingVision
Head of Clinical Operations for Gene Therapies at SparingVision
(January 2023 – Present)
General Counsel / Directrice juridique
Chief Legal Officer / Directrice Juridique at ENYO Pharma
(September 2026 – September 2026)
Biotechnology engineer
Associate Scientist at SparingVision
(October 2023 – Present)
Nonclinical Associate Manager chez SparingVision
Nonclinical Associate Manager - Development Sciences at SparingVision
(January 2022 – Present)
Senior Scientist Gene Editing, Sparing Vision
Postdoctoral Researcher at Ocular Genomics Institute
(September 2026 – September 2026)
Pharmacien Affaires Réglementaires
Senior Manager Regulatory Affairs at SparingVision
(February 2019 – Present)
What is Anne Celle email address?
Email Anne Celle at [email protected]. This email is the most updated Anne Celle's email found in 2026.
How to contact Anne Celle?
To contact Anne Celle send an email to [email protected].
What company does Anne Celle work for?
Anne Celle works for SparingVision.
What is Anne Celle's role at SparingVision?
Anne Celle is Clinical Project Manager
What industry does Anne Celle work in?
Anne Celle works in the Research industry.